Cargando…
THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES
OBJECTIVE: The aim of this study is to determine the differential algorithm between rheumatism and malignant diseases. For every pediatrician, to be warned when attending joint pain and child arthralgia and prevent and treat within time malignant diseases. METHODS: Our case presented in Pediatric Cl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851544/ https://www.ncbi.nlm.nih.gov/pubmed/27147926 http://dx.doi.org/10.5455/msm.2016.28.156-158 |
_version_ | 1782429836416909312 |
---|---|
author | Këpuska, Arbnore Batalli Spahiju, Lidvana Bejiq, Ramush Manqestena, Rufadije Stavileci, Valbona Ibraimi, Zana |
author_facet | Këpuska, Arbnore Batalli Spahiju, Lidvana Bejiq, Ramush Manqestena, Rufadije Stavileci, Valbona Ibraimi, Zana |
author_sort | Këpuska, Arbnore Batalli |
collection | PubMed |
description | OBJECTIVE: The aim of this study is to determine the differential algorithm between rheumatism and malignant diseases. For every pediatrician, to be warned when attending joint pain and child arthralgia and prevent and treat within time malignant diseases. METHODS: Our case presented in Pediatric Clinic, was referred by Regional Hospital of Ferizaj with suspected diagnose of Febris Rheumatica and Arthralgia. The main complaint was joint pain. Initially the patient was admitted at Cardiology and Rheumatology department. Then after examinations was referred to Hemato-Oncology department. Hospitalized during the period from 12.12.2014 to 18.01.2015. RESULTS: Bone marrow biopsy as terminal diagnostic tool reviled severe malignant hematologic disease, which was masked by clinical and lab findings as Febris Rheumatica. CONCLUSION: Arthralgia as one of child’s often complain, should have a special attention paid to, as it might be a warning sign for a lot of diseases. Steroid treatment should not be used before final diagnose of the disease and before rolling out hematologic etiology with peripheral blood smear. |
format | Online Article Text |
id | pubmed-4851544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-48515442016-05-04 THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES Këpuska, Arbnore Batalli Spahiju, Lidvana Bejiq, Ramush Manqestena, Rufadije Stavileci, Valbona Ibraimi, Zana Mater Sociomed Case Report OBJECTIVE: The aim of this study is to determine the differential algorithm between rheumatism and malignant diseases. For every pediatrician, to be warned when attending joint pain and child arthralgia and prevent and treat within time malignant diseases. METHODS: Our case presented in Pediatric Clinic, was referred by Regional Hospital of Ferizaj with suspected diagnose of Febris Rheumatica and Arthralgia. The main complaint was joint pain. Initially the patient was admitted at Cardiology and Rheumatology department. Then after examinations was referred to Hemato-Oncology department. Hospitalized during the period from 12.12.2014 to 18.01.2015. RESULTS: Bone marrow biopsy as terminal diagnostic tool reviled severe malignant hematologic disease, which was masked by clinical and lab findings as Febris Rheumatica. CONCLUSION: Arthralgia as one of child’s often complain, should have a special attention paid to, as it might be a warning sign for a lot of diseases. Steroid treatment should not be used before final diagnose of the disease and before rolling out hematologic etiology with peripheral blood smear. AVICENA, d.o.o., Sarajevo 2016-04 2016-03-25 /pmc/articles/PMC4851544/ /pubmed/27147926 http://dx.doi.org/10.5455/msm.2016.28.156-158 Text en Copyright: © Arbnore Batalli Këpuska, Lidvana Spahiju, Ramush Bejiq, Rufadije Manqestena, Valbona Stavileci, and Zana Ibraimi http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Këpuska, Arbnore Batalli Spahiju, Lidvana Bejiq, Ramush Manqestena, Rufadije Stavileci, Valbona Ibraimi, Zana THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES |
title | THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES |
title_full | THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES |
title_fullStr | THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES |
title_full_unstemmed | THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES |
title_short | THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES |
title_sort | differential algorithm between rheumatologic and malign diseases |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851544/ https://www.ncbi.nlm.nih.gov/pubmed/27147926 http://dx.doi.org/10.5455/msm.2016.28.156-158 |
work_keys_str_mv | AT kepuskaarbnorebatalli thedifferentialalgorithmbetweenrheumatologicandmaligndiseases AT spahijulidvana thedifferentialalgorithmbetweenrheumatologicandmaligndiseases AT bejiqramush thedifferentialalgorithmbetweenrheumatologicandmaligndiseases AT manqestenarufadije thedifferentialalgorithmbetweenrheumatologicandmaligndiseases AT stavilecivalbona thedifferentialalgorithmbetweenrheumatologicandmaligndiseases AT ibraimizana thedifferentialalgorithmbetweenrheumatologicandmaligndiseases AT kepuskaarbnorebatalli differentialalgorithmbetweenrheumatologicandmaligndiseases AT spahijulidvana differentialalgorithmbetweenrheumatologicandmaligndiseases AT bejiqramush differentialalgorithmbetweenrheumatologicandmaligndiseases AT manqestenarufadije differentialalgorithmbetweenrheumatologicandmaligndiseases AT stavilecivalbona differentialalgorithmbetweenrheumatologicandmaligndiseases AT ibraimizana differentialalgorithmbetweenrheumatologicandmaligndiseases |